Table 7.
Univariate Kaplan-Meier and Cox regression analysis for duplicate parameters
| Survival time | Log-rank p-value | Univariate Cox Regression HR (95%C.I.) | HR p-value | |||
|---|---|---|---|---|---|---|
| Mean±SE | Median±SE | |||||
| MTD<5 cm | GGT ≤100 | 69.67±5.74 | 60±19.01 | 0.023 | reference | |
| GGT >100 | 40.23±5.82 | 38±12.15 | 1.73 (1.07–2.81) | 0.026 | ||
| MTD≥5 cm | GGT ≤100 | 54.29±5.85 | 36±8.03 | 0.011 | reference | |
| GGT >100 | 26.01±3.34 | 24±4.93 | 1.63 (1.11–2.39) | 0.013 | ||
| MTD<5 cm | GGT ≤100 & ALB>3.5 | 83.03±8.42 | NA | 0.002 | reference | |
| GGT >100 & ALB≤3.5 | 40.74±7.58 | 38±10.24 | 2.99 (1.45–6.19) | 0.003 | ||
| MTD≥5 cm | GGT ≤100 & ALB>3.5 | 63.10±7.95 | 45±8.50 | <0.001 | reference | |
| GGT >100 & ALB≤3.5 | 28.12±3.93 | 24±5.82 | 2.67 (1.52–4.71) | 0.001 | ||
| MTD<5 cm | GGT ≤100 & AST≤40 | 86.29±8.53 | NA | 0.001 | reference | |
| GGT >100 & AST>40 | 37.68±5.95 | 38±9.21 | 3.01 (1.47–6.14) | 0.002 | ||
| MTD≥5 cm | GGT ≤100 & AST≤40 | 53.94±8.33 | 52±12.19 | 0.005 | reference | |
| GGT >100 & AST>40 | 21.10±3.31 | 16±3.45 | 2.25 (1.25–4.07) | 0.007 | ||
| MTD<5 cm | GGT ≤100 & ALKP>100 | 73.80±9.86 | NA | 0.346 | reference | |
| GGT >100 & ALKP≤100 | 36.66±7.93 | 26±11.72 | 1.57 (0.61–4.05) | 0.352 | ||
| MTD≥5 cm | GGT ≤100 & ALKP>100 | 56.33±8.21 | 30±16.02 | 0.037 | reference | |
| GGT >100 & ALKP≤100 | 13.11±5.29 | 9±5.00 | 2.66 (1.01–7.02) | 0.048 | ||
Abbreviations: MTD: Maximum tumor diameter; GGT: Gamma Glutamyl transpeptidase (IU/mL); ALB: Albumin (g/dL); AST: Aspartate aminotransferase (IU/L); ALKP: Alkaline phosphatase (IU/Ml)